FilingReader Intelligence

Guangdong Hybribio Biotech schedules extraordinary general meeting for September 10

September 5, 2025 at 05:15 AM UTCBy FilingReader AI

Guangdong Hybribio Biotech Co., Ltd. will convene its first extraordinary general meeting of shareholders for 2025 on September 10, 2025, at 3:00 p.m. The meeting will be held through a combination of on-site voting and online polling, with the record date set for September 4, 2025. Online voting via the Shenzhen Stock Exchange trading system will be open from 9:15-9:25 a.m., 9:30-11:30 a.m., and 1:00-3:00 p.m. on September 10, 2025.

The agenda includes critical resolutions such as revising the company's Articles of Association, Rules of Procedure for Shareholders' Meetings, Rules of Procedure for Board Meetings, Management System for Raised Funds, and Management System for Related Party Transactions. Additionally, the meeting will address the re-election of the sixth board of directors, including five non-independent directors and three independent directors. Resolutions 1-3, concerning the amendments to the Articles of Association and rules of procedure, require a two-thirds majority vote from attending shareholders.

Shareholders wishing to attend in person must register by September 9, 2025, 5:00 p.m., with on-site registration available from 2:00-3:00 p.m. on the day of the meeting. The company will count votes from small and medium-sized investors separately for all resolutions.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:300639Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Guangdong Hybribio Biotech publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →